
High-dose intravenous immunoglobulin appeared to reverse deteriorating courses of COVID-19 in 3 case reports from Wuhan, China.

High-dose intravenous immunoglobulin appeared to reverse deteriorating courses of COVID-19 in 3 case reports from Wuhan, China.

A new study is providing more information on the link between cardiac injury and mortality among patients hospitalized with COVID-19.

This is not the first infectious challenge society has faced, and nor will it be the last.

Patients facing HIV stigma may encounter difficulties with retention in care.

From epidemiology to treatment modalities, this is very much a learn-as-we-go situation.

The FDA has issued a safety alert on the potential risk of transmitting SARS-CoV-2, the virus that causes coronavirus diseases 2019 (COVID-19), through fecal microbiota transplantation.

Stay up to date with the latest COVID-19 news from Contagion.

Investigations in the US and China make a case for using convalescent plasma, a “last resort” for SARS, as an early treatment for COVID-19.

A new serological assay was developed by a microbiology lab at the Icahn School of Medicine at Mount Sinai.

World Tuberculosis Day is commemorated annually on March 24 to heighten awareness of the world’s most deadly infectious disease.

From PPE shortages to scared staff, what are hospitals currently facing and how can they respond?

The analysis included countries around the world, but the investigators also classified the data by WHO region.

Close adherence to recommendations for preventing health-care associated transmission is key to preventing health care-associated transmission of carbapenem-resistant Enterobacteriaceae, a review of a skilled nursing facility in Arizona suggests.

Stay up to date with the latest COVID-19 news from Contagion.

Jason Pogue, PharmD, BCPS, BCIDP, shares his thoughts on a study published in the International Journal of Antimicrobial Agents.

Contagion is partnering with PER to host a live CME-Certified webinar on what clinicians need to know about COVID-19.

The impact of COVID-19 on cardiovascular health is an urgent question for clinicians around the world during this global pandemic.

A study has examined the availability of negative vaccine information online.

A Central Science report from the CAS division of the American Chemical Society details developments and recommends directions against COVID-19 pandemic.

The vast majority of patients with a documented penicillin allergy are not actually at risk from the antibiotic. New research aims to help remove the “allergic” label from some patients’ records.

Countries around the world have struggled to keep the spread of COVID-19 in check. In countries with relatively few resources and weak public health infrastructure, the challenge is even more acute.

A quick and effective response by health officials in Uganda stopped a case of imported pneumonic plague from spreading, according to a recent Morbidity and Mortality Weekly Report.

What does it look like when a health system switches from 'containment' to 'mitigation'?

Older people in low-income countries are especially at risk for COVID-19.

The European Union is rethinking its approach to border crossings as the region deals with the COVID-19 pandemic.

FDA grants emergency use authorization for Cepheid's point-of-care COVID-19 diagnostic, Xpert Xpress SARS-CoV-2.

Lopinavir-ritonavir worked against SARS, but it had little effect against coronavirus compared to standard care.

Here is a look at infectious disease-related FDA news from the week of March 15, 2020.

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

Stay on top of coronavirus developments from March 20, 2020.